Pluripotent adult stem cells
Patent Number: 7,259,011
Date of First Priority Issue: Thursday May 20th, 2004
Date Issued: Tuesday August 21st, 2007
Assignee: Unknown Assignee(s)
Inventors: Lucas; Paul (Poughkeepsie, NY), Schultz; Sherri (Katonah, NY), Pine; Sharon P. (Montgomery Village, MD)
From Class: Type
Comments: No comments
This patent covers a stem cell that is positive for expression of CD13, CD34, CD56 and CD117, negative for CD10. Dependent claims further cover the phenotype of CD2, CD5, CD14, CD19, CD33, CD45, and DRII negative, CD13,CD34, CD56, CD90, CD117 positive, and CD2, CD3, CD10, CD14, CD16, CD31, CD33, CD45 and CD64 negative. The stem cell can be derived from the muscle or bone marrow.
The inventors demonstrated that the cell type they are claiming can differentiated into neurons, adipocytes, and myocytes in the examples section of the patent.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday August 26th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.